During the week of June 15, 2026, FDA issued 25 warning letters to telehealth companies over alleged false or misleading promotional claims about compounded GLP-1 productsclaims the agency views as violating the Federal Food, Drug, and Cosmetic Acts (FDCA) misbranding provisions, including Sections 502(a) and 502(n)
Combined with a healthier lifestyle, this individual lost 15 pounds in 60 days
This question concerns many patients prescribed glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda) for type 2 diabetes or weight management
5,15,16 GLP-1 RAs have been reported to improve atherosclerosis by shifting macrophage function and changing inflammatory pathways
Malissa, Tracy, and everyone are simply great